Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binfeng Lu

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|September 3, 2017
Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic CellsTrevor Smith, Xiaotian Lin, Marielle Mello, et al.
Cancer Immunology Research|February 12, 2024
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in CancerHan Zhang, Sanghoon Lee, Renee R Muthakana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell deathChangyou Li, Elizabeth Capan, Yani Zhao, et al.
Frontiers in Cell and Developmental Biology|February 8, 2021
Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8<sup>+</sup> T CellsRunzi Sun, Yixian Wu, Huijun Zhou, et al.
Plos One|August 31, 2011
Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/OxaliplatinJingting Jiang, Xiao Zheng, Xiao Xu, et al.
European Journal of Immunology|August 19, 2009
Gadd45b and Gadd45g are important for anti-tumor immune responsesSongguang Ju, Yibei Zhu, Lin Liu, et al.
Plos One|March 19, 2014
An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinomaYichen Tang, Xuejun Xu, Shixiang Guo, et al.
International Journal of Molecular Sciences|March 17, 2017
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of ActionWenwen Du, Min Yang, Abbey Turner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2010
T-bet and eomesodermin are required for T cell-mediated antitumor immune responsesYibei Zhu, Songguang Ju, Elizabeth Chen, et al.
World Journal of Surgical Oncology|October 3, 2013
Characteristic analysis of α-fetoprotein-producing gastric carcinoma in ChinaXiao-Dong Li, Chang-Ping Wu, Mei Ji, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|September 3, 2017
Peripheral Deletion of CD8 T Cells Requires p38 MAPK in Cross-Presenting Dendritic CellsTrevor Smith, Xiaotian Lin, Marielle Mello, et al.
Cancer Immunology Research|February 12, 2024
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and Response to Immune Checkpoint Blockade in CancerHan Zhang, Sanghoon Lee, Renee R Muthakana, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2006
Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell deathChangyou Li, Elizabeth Capan, Yani Zhao, et al.
Frontiers in Cell and Developmental Biology|February 8, 2021
Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8<sup>+</sup> T CellsRunzi Sun, Yixian Wu, Huijun Zhou, et al.
Plos One|August 31, 2011
Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S-1/Oxaliplatin or Doxifluridine/OxaliplatinJingting Jiang, Xiao Zheng, Xiao Xu, et al.
European Journal of Immunology|August 19, 2009
Gadd45b and Gadd45g are important for anti-tumor immune responsesSongguang Ju, Yibei Zhu, Lin Liu, et al.
Plos One|March 19, 2014
An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinomaYichen Tang, Xuejun Xu, Shixiang Guo, et al.
International Journal of Molecular Sciences|March 17, 2017
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of ActionWenwen Du, Min Yang, Abbey Turner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2010
T-bet and eomesodermin are required for T cell-mediated antitumor immune responsesYibei Zhu, Songguang Ju, Elizabeth Chen, et al.
World Journal of Surgical Oncology|October 3, 2013
Characteristic analysis of α-fetoprotein-producing gastric carcinoma in ChinaXiao-Dong Li, Chang-Ping Wu, Mei Ji, et al.
Pageof 12